Learn more

SIGNALRX PHARMACEUTICALS INC

Overview
  • Total Patents
    15
  • GoodIP Patent Rank
    131,779
  • Filing trend
    ⇧ 600.0%
About

SIGNALRX PHARMACEUTICALS INC has a total of 15 patent applications. It increased the IP activity by 600.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are GLACTONE PHARMA DEV AB, CHONG KUN DANG PHARMACEUTICAL CORP and HELSINN THERAPEUTICS US INC.

Patent filings in countries

World map showing SIGNALRX PHARMACEUTICALS INCs patent filings in countries
# Country Total Patents
#1 United States 8
#2 WIPO (World Intellectual Property Organization) 4
#3 EPO (European Patent Office) 3

Patent filings per year

Chart showing SIGNALRX PHARMACEUTICALS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Garlich Joseph R 11
#2 Morales Guillermo A 10
#3 Durden Donald L 8
#4 Durden Donald 4
#5 Garlich Joseph 4
#6 Morales Guillermo 3
#7 Weber Kevin T 2
#8 Newblom Jessica M 2
#9 Weber Kevin 2
#10 Newblom Jessica 2

Latest patents

Publication Filing date Title
WO2020023340A1 Single molecule compounds providing multi-target inhibition of btk and other proteins and methods of use thereof
WO2018236971A1 Single molecule compounds providing multi-target inhibition of parp and other proteins and methods of use thereof
WO2018226739A1 Thienopyranones and furanopyranones as checkpoint inhibitors and modulatiors of anti-tumor immunity
WO2018140730A1 Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors
US2015315207A1 Heterocyclic compound classes for signaling modulation
US2015344494A1 Thienopyranones as kinase and epigenetic inhibitors